Author:
Price Katharine A.R.,Azzoli Christopher G.,Gaspar Laurie E.
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery
Reference16 articles.
1. A phase II study of pemetrexed, carboplatin and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small cell lung cancer: CALGB 30407–early evaluation of feasibility and toxicity;Govindan;J Clin Oncol,2008
2. Improved survival in stage III non-small cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial;Dillman;J Natl Cancer Inst,1996
3. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group;Sause;Chest,2000
4. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer;Furuse;J Clin Oncol,1999
5. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410;Curran;J Clin Oncol,2003